207 related articles for article (PubMed ID: 29400015)
1. Trends of uterine carcinosarcoma in the United States.
Matsuo K; Ross MS; Machida H; Blake EA; Roman LD
J Gynecol Oncol; 2018 Mar; 29(2):e22. PubMed ID: 29400015
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Rojas C; Tian C; Powell MA; Chan JK; Bateman NW; Conrads TP; Rocconi RP; Jones NL; Shriver CD; Hamilton CA; Maxwell GL; Casablanca Y; Darcy KM
Gynecol Oncol; 2020 Apr; 157(1):67-77. PubMed ID: 32029291
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma.
Van Arsdale AR; Arend RC; Cossio MJ; Erickson BK; Wang Y; Doo DW; Leath CA; Goldberg GL; Huang GS
Cancer Med; 2018 Mar; 7(3):616-625. PubMed ID: 29455465
[TBL] [Abstract][Full Text] [Related]
4. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.
Brooks SE; Zhan M; Cote T; Baquet CR
Gynecol Oncol; 2004 Apr; 93(1):204-8. PubMed ID: 15047237
[TBL] [Abstract][Full Text] [Related]
5. Assessing endometrial cancer risk among US women: long-term trends using hysterectomy-adjusted analysis.
Doll KM; Winn AN
Am J Obstet Gynecol; 2019 Oct; 221(4):318.e1-318.e9. PubMed ID: 31125544
[TBL] [Abstract][Full Text] [Related]
6. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant radiation therapy in uterine carcinosarcoma: A population-based analysis of patient demographic and clinical characteristics, patterns of care and outcomes.
Manzerova J; Sison CP; Gupta D; Holcomb K; Caputo TA; Parashar B; Nori D; Wernicke AG
Gynecol Oncol; 2016 May; 141(2):225-230. PubMed ID: 26896827
[TBL] [Abstract][Full Text] [Related]
8. Incidence and survival rates of primary uterine carcinosarcoma in Korea: a National Cancer Registry study.
Kim SI; Kim JH; Lee C; Ha J; Jung KW; Lim MC
J Gynecol Oncol; 2023 Jan; 34(1):e9. PubMed ID: 36366811
[TBL] [Abstract][Full Text] [Related]
9. Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database.
Hosh M; Antar S; Nazzal A; Warda M; Gibreel A; Refky B
Int J Gynecol Cancer; 2016 Jul; 26(6):1098-104. PubMed ID: 27177280
[TBL] [Abstract][Full Text] [Related]
10. Uterine and Ovarian Carcinosarcomas: Do They Behave Similarly?
Ureyen I; Karalok A; Cirik DA; Tasci T; Gokce ZK; Duzguner IB; Tulunay G; Turan T
J Obstet Gynaecol Can; 2017 Jul; 39(7):559-563. PubMed ID: 28625283
[TBL] [Abstract][Full Text] [Related]
11. Uterine carcinosarcoma: A review of the literature.
Cantrell LA; Blank SV; Duska LR
Gynecol Oncol; 2015 Jun; 137(3):581-8. PubMed ID: 25805398
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
Abel MK; Liao CI; Chan C; Lee D; Rohatgi A; Darcy KM; Tian C; Mann AK; Maxwell GL; Kapp DS; Chan JK
Gynecol Oncol; 2021 May; 161(2):470-476. PubMed ID: 33722415
[TBL] [Abstract][Full Text] [Related]
13. Identification of distinct molecular subtypes of uterine carcinosarcoma.
An Y; Wang H; Jie J; Tang Y; Zhang W; Ji S; Guo X
Oncotarget; 2017 Feb; 8(9):15878-15886. PubMed ID: 28178664
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcoma: a primer for radiologists.
Ravishankar P; Smith DA; Avril S; Kikano E; Ramaiya NH
Abdom Radiol (NY); 2019 Aug; 44(8):2874-2885. PubMed ID: 31030248
[TBL] [Abstract][Full Text] [Related]
16. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
Garg G; Kruger M; Christensen C; Deppe G; Toy EP
Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.
Uehara T; Onda T; Togami S; Amano T; Tanikawa M; Sawada M; Ikeda S; Kato T; Kasamatsu T
Int J Gynecol Cancer; 2012 Feb; 22(2):280-5. PubMed ID: 22228427
[TBL] [Abstract][Full Text] [Related]
18. Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 years.
Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MM; Ueland FR; Kelley JL; Roman LD
Surg Oncol; 2019 Jun; 29():25-32. PubMed ID: 31196490
[TBL] [Abstract][Full Text] [Related]
19. Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta-analysis of survival.
Raffone A; Travaglino A; Raimondo D; Maletta M; De Vivo V; Visiello U; Casadio P; Seracchioli R; Zullo F; Insabato L; Mollo A
Int J Gynaecol Obstet; 2022 Sep; 158(3):520-527. PubMed ID: 34797919
[TBL] [Abstract][Full Text] [Related]
20. Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous element.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Yanai S; Takeuchi S; Nishimura M; Iwasaki K; Johnson MS; Yoshida M; Hakam A; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Kajiwara H; Hasegawa K; Yasuda M; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Pejovic T; Nagano T; Sasaki T; Richmond AM; Post MD; Shahzad MMK; Im DD; Yoshida H; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Surg Oncol; 2018 Sep; 27(3):433-440. PubMed ID: 30217299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
